Ekso bionics announces pricing of $6.0 million underwritten public offering

San rafael, calif., aug. 29, 2024 (globe newswire) -- ekso bionics holdings, inc. (nasdaq: ekso) (the “company” or “ekso bionics”), an industry leader in exoskeleton technology for medical and industrial use, today announced the pricing of an underwritten public offering of 6,000,000 total units and pre-funded units for gross proceeds of approximately $6.0 million prior to deducting underwriting discounts and commissions and offering expenses. the offering is comprised of 3,100,000 units, priced at a public offering price of $1.00 per unit, with each unit consisting of one share of common stock, one warrant to purchase one share of common stock at an exercise price of $1.00 per share that expires on the fifth anniversary of the date of issuance (a “series a warrant”) and one warrant to purchase one share of common stock at an exercise price of $1.00 per share that expires on the first anniversary of the date of issuance (a “series b warrant”) and (ii) 2,900,000 pre-funded units, priced at a public offering price of $0.999 per unit, with each unit consisting of one pre-funded warrant to purchase one share of common stock at an exercise price of $0.001 per share, one series a warrant and one series b warrant. the securities comprising the units and pre-funded units are immediately separable and will be issued separately.
EKSO Ratings Summary
EKSO Quant Ranking